And so we actually have in our clinical trials an important focus on collecting patient reported outcomes, in addition to looking at hematologic parameters.

Source: https://seekingalpha.com/article/4604184-editas-medicine-inc-edit-bank-of-america-global-healthcare-conference-call-transcript?source=feed_all_articles

As expected with combination chemotherapy, the most common side effects included gastrointestinal and hematologic toxicities, and fatigue.

Source: https://www.prnewswire.com/news-releases/phase-3-swog-cancer-research-network-trial-led-by-a-city-of-hope-researcher-demonstrates-one-year-progression-free-survival-in-94-of-patients-with-stage-3-or-4-classic-hodgkin-lymphoma-who-received-a-checkpoint-inh

Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.

Source: https://www.etfdailynews.com/2023/06/23/disc-medicine-opco-nasdaqiron-shares-gap-up-to-52-98/

It is also evaluating SL-172154 in an ongoing Phase I clinical trial for the treatment of patients with certain hematologic malignancies, including acute myeloid leukemia (AML), and higher-risk myelodysplastic syndromes (HR-MDS).

Source: https://www.marketscreener.com/quote/stock/SHATTUCK-LABS-INC-113534508/news/Shattuck-Labs-Announces-50-Million-Public-Offering-of-Common-Stock-and-Concurrent-Private-Placement-45617405/?utm_medium=RSS&utm_content=20231221